Intra-Cellular Therapies, Inc. Annual Depreciation in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
  • Intra-Cellular Therapies, Inc. Depreciation for the quarter ending March 31, 2024 was $132K, a 1.49% decline year-over-year.
  • Intra-Cellular Therapies, Inc. annual Depreciation for 2023 was $528K, a 19.5% decline from 2022.
  • Intra-Cellular Therapies, Inc. annual Depreciation for 2022 was $656K, a 23.1% increase from 2021.
  • Intra-Cellular Therapies, Inc. annual Depreciation for 2021 was $533K, a 0.95% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $528K -$128K -19.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $656K +$123K +23.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $533K +$5K +0.95% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $528K +$50.9K +10.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $477K +$108K +29.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $369K +$155K +72.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $214K +$17K +8.64% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $197K +$57.2K +41% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $140K +$114K +448% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $25.5K +$2.23K +9.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 $23.2K -$24.5K -51.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
2012 $47.7K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.